Pheno Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
65 Haymarket Ter Fl 3, Edinburgh, Midlot...Website
www.phenotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pheno Therapeutics
Pheno Therapeutics is a clinical stage biotech company focused on developing GPR17 antagonists to address neurodegenerative and demyelinating disorders. Their innovative approach targets oligodendrocytes, which are crucial for brain function and are compromised in various CNS diseases. The company aims to transform the quality of life for patients suffering from conditions such as multiple sclerosis, Alzheimer's disease, and ALS. With a team of experienced biotech executives and academic leaders, Pheno Therapeutics is dedicated to delivering first and best-in-class neuroprotective therapeutics.Explore more
Pheno Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pheno Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Pheno Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Pheno Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pheno Therapeutics recently announced quarterly report
Product Launch: Get notified when Pheno Therapeutics launches new products
Click to see if Pheno Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Pheno Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pheno Therapeutics
Pheno Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Pheno Therapeutics
Compare insights from companies similar to Pheno Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pheno Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pheno Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pheno Therapeutics.
Pheno Therapeutics Tech Stack
A closer look at the technologies used by Pheno Therapeutics
Pheno Therapeutics News & Media
Pheno Therapeutics Announces Worldwide License From UCB to a Novel Program for Neurodegenerative Disease
EDINBURGH, Scotland--(BUSINESS WIRE)--Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics that promote remyelination for the treatment of neurological diseases such as multiple sclerosis, announced today it has entered into an exclusive worldwide license agreement with UCB. The agreement grants Pheno Therapeutics access and rights to develop, manufacture and commercialize a preclinical-stage program of novel small molecule
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pheno Therapeutics
Sign Up For FreeTo access detailed company insights
Pheno Therapeutics is a clinical stage biotech company focused on developing GPR17 antagonists to address neurodegenerative and demyelinating disorders. Their innovative approach targets oligodendrocytes, which are crucial for brain function and are compromised in various CNS diseases. The company aims to transform the quality of life for patients... Read More
